Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Private Management Group Holds 9.6% Stake in Orion Properties

Private Management Group, Inc. filed a Schedule 13G Amendment No. 2 with the SEC on November 9, 2026, disclosing a beneficial ownership position in Orion Properties Inc. common stock as of September 30, 2026.

Vinay Lochav | 09 November 2026

Private Management Group Discloses 5.0% Stake in Greenlight Capital Re

Private Management Group, Inc. filed a Schedule 13G with the SEC on November 9, 2026, disclosing beneficial ownership of 1,626,461 shares of Greenlight Capital Re, Ltd. common stock, representing 5.0% of the class, as of September 30, 2026.

Nitish Kishor | 09 November 2026

Private Management Group Holds 9.9% of Cable One Common Stock

Private Management Group, Inc. filed Amendment No. 2 to its Schedule 13G with the SEC on November 9, 2026, disclosing a 9.9% beneficial ownership stake in Cable One, Inc. common stock as of September 30, 2026.

Shwetambri Chauhan | 09 November 2026

Takeover Time Calls CTNT Stockholders to Green Consent Card

Takeover Time 2026 LLC filed definitive additional soliciting materials with the SEC on November 9, 2026, pressing Cheetah Net Supply Chain Service Inc. stockholders to use a green consent card to replace the company's incumbent board of directors.

Vinay Lochav | 09 November 2026

Morgan Stanley NVO Auto-Callable Notes Due Dec 2027

Morgan Stanley Finance LLC filed a free writing prospectus on November 9, 2026, disclosing terms for Contingent Income Auto-Callable Securities linked to Novo Nordisk A/S American depositary shares, with a maturity date of December 29, 2027.

Shwetambri Chauhan | 09 November 2026

Goldman Sachs Reports 1.0% Stake in Definitive Healthcare

The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC filed Amendment No. 2 to a Schedule 13G with the SEC on November 9, 2026, disclosing their beneficial ownership of Class A Common Stock in Definitive Healthcare Corp as of September 30, 2026.

Aditi Sarkar | 09 November 2026

Goldman Sachs Reports 0.9% Stake in Karyopharm Therapeutics

The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC filed Amendment No. 2 to a Schedule 13G with the SEC, disclosing beneficial ownership of common stock in Karyopharm Therapeutics Inc. as of September 30, 2026.

Shwetambri Chauhan | 09 November 2026

Linde PLC: Binod Patwari Plans Sale of 2,500 Shares

A Form 144 notice of proposed sale was filed on November 9, 2026, disclosing that Binod Patwari, a former officer of Linde PLC, intends to sell 2,500 shares of Linde common stock through Fidelity Brokerage Services LLC.

Nitish Kishor | 09 November 2026

Morgan Stanley Worst-of INDU, RTY, SPX Notes Due Dec 2033

Morgan Stanley Finance LLC filed a Free Writing Prospectus to Preliminary Pricing Supplement No. 20,005 on November 9, 2026, disclosing the terms of Worst-of INDU, RTY and SPX Trigger Jump Securities due December 6, 2033.

Aditi Sarkar | 09 November 2026

Tracx Logis Lists Ordinary Shares on Nasdaq via Form 8-A

Tracx Logis Ltd. filed a Form 8-A on November 9, 2026, to register its Ordinary Shares, no par value, for listing on The Nasdaq Stock Market LLC under Section 12(b) of the Securities Exchange Act of 1934.

Vinay Lochav | 09 November 2026
Support

Hi! How can we help you today?

Loading…